1. AHRO : Austin Health Research Online

Vijayaragavan Muralidharan

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Vijayaragavan Muralidharan
Full Name
Muralidharan, Vijayaragavan
 
Muralidharan.jpg picture
Department
 
Personal Site
 
ORCID
Twitter
Biography
Associate Professor Vijayaragavan Muralidharan is the supervisor of General Surgical training at Austin Health and a long-time mentor to many trainees. He has an extensive background in clinical and basic science research.
 
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Malcontenti-Wilson, Caterina

Results 1-19 of 19 (Search time: 0.018 seconds).

Publication YearTitleAuthor(s)
118-Aug-2013Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.Fifis, Theodora; Nguyen, Linh; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Nunes Costa, Patricia Luiza; Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Waltham, Mark; Thompson, Erik W; Christophi, Christopher 
215-Nov-2012Spatial morphological and molecular differences within solid tumors may contribute to the failure of vascular disruptive agent treatments.Nguyen, Linh; Fifis, Theodora; Malcontenti-Wilson, Caterina; Chan, Lie Sam; Costa, Patricia Nunes Luiza; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher 
323-Sep-2012Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function.Koh, Shir Lin; Ager, Eleanor I; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher 
413-Nov-2011Hyperbaric oxygen therapy reduces the severity of ischaemia, preservation and reperfusion injury in a rat model of liver transplantation.Tran, Nhut Quang; Malcontenti-Wilson, Caterina; Hammoud, Soukena; Millar, Ian; Christophi, Christopher ; Muralidharan, Vijayaragavan 
529-May-2011Induction of Th1Immune responses following laser ablation in a murine model of colorectal liver metastases.Lin, Wen Xu; Fifis, Theodora; Malcontenti-Wilson, Caterina; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Nguyen, Linh; Christophi, Christopher 
62-Mar-2011Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.Fifis, Theodora; Malcontenti-Wilson, Caterina; Amijoyo, Jason; Anggono, Beatrice; Muralidharan, Vijayaragavan ; Nikfarjam, Mehrdad ; Christophi, Christopher 
717-May-2010In vitro and in vivo evaluation of tumor targeting styrene-maleic acid copolymer-pirarubicin micelles: Survival improvement and inhibition of liver metastases.Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Greish, Khaled; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher ; Maeda, Hiroshi
827-Oct-2008Styrene maleic acid-pirarubicin disrupts tumor microcirculation and enhances the permeability of colorectal liver metastases.Daruwalla, Jurstine; Greish, Khaled; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Iyer, Arun; Maeda, Hiroshi; Christophi, Christopher 
91-Jan-2008Alterations in vascular architecture and permeability following OXi4503 treatment.Chan, Lie Sam; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher 
101-Nov-2007Hyperbaric oxygen therapy for severe acute pancreatitis.Christophi, Christopher ; Millar, Ian; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Malcontenti-Wilson, Caterina
111-Aug-2007Hyperbaric oxygen therapy reduces severity and improves survival in severe acute pancreatitis.Nikfarjam, Mehrdad ; Cuthbertson, Christine M; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Millar, Ian; Christophi, Christopher 
128-Jul-2007Effect of vascular targeting agent Oxi4503 on tumor cell kinetics in a mouse model of colorectal liver metastasis.Chan, Lie Sam; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher 
137-Jun-2007Vascular targeting agent Oxi4503 inhibits tumor growth in a colorectal liver metastases model.Malcontenti-Wilson, Caterina; Chan, Lisa; Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Christophi, Christopher 
141-Apr-2007Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases.Neo, Jaclyn H; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher 
152-Jan-2006Impact of blood flow occlusion on liver necrosis following thermal ablation.Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Malcontenti-Wilson, Caterina; McLaren, Wendy; Christophi, Christopher 
161-Aug-2005Effect of thalidomide on colorectal cancer liver metastases in CBA mice.Daruwalla, Jurstine; Nikfarjam, Mehrdad ; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan ; Christophi, Christopher 
171-Jul-2005Progressive microvascular injury in liver and colorectal liver metastases following laser induced focal hyperthermia therapy.Nikfarjam, Mehrdad ; Muralidharan, Vijayaragavan ; Malcontenti-Wilson, Caterina; Christophi, Christopher 
1829-Sep-2004Long-term survival of patients with unresectable colorectal liver metastases treated by percutaneous interstitial laser thermotherapy.Christophi, Christopher ; Nikfarjam, Mehrdad ; Malcontenti-Wilson, Caterina; Muralidharan, Vijayaragavan 
195-Dec-2003Effect of interstitial laser hyperthermia in a murine model of colorectal liver metastases: scanning electron microscopic study.Muralidharan, Vijayaragavan ; Nikfarjam, Mehrdad ; Malcontenti-Wilson, Caterina; Christophi, Christopher